Unknown

Dataset Information

0

RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.


ABSTRACT: The N6-methyladenosine (m6A) RNA-binding protein YTHDF1 is frequently overexpressed in colorectal cancer and drives chemotherapeutic resistance. To systematically identify druggable targets in colorectal cancer with high expression of YTHDF1, this study used a CRISPR/Cas9 screening strategy that revealed RUVBL1 and RUVBL2 as putative targets. RUVBL1/2 were overexpressed in primary colorectal cancer samples and represented independent predictors of poor patient prognosis. Functionally, loss of RUVBL1/2 preferentially impaired the growth of YTHDF1-high colorectal cancer cells, patient-derived primary colorectal cancer organoids, and subcutaneous xenografts. Mechanistically, YTHFD1 and RUVBL1/2 formed a positive feedforward circuit to accelerate oncogenic translation. YTHDF1 bound to m6A-modified RUVBL1/2 mRNA to promote translation initiation and protein expression. Coimmunoprecipitation and mass spectrometry identified that RUVBL1/2 reciprocally interacted with YTHDF1 at 40S translation initiation complexes. Consequently, RUVBL1/2 depletion stalled YTHDF1-driven oncogenic translation and nascent protein biosynthesis, leading to proliferative arrest and apoptosis. Ribosome sequencing revealed that RUVBL1/2 loss impaired the activation of MAPK, RAS, and PI3K-AKT signaling induced by YTHDF1. Finally, the blockade of RUVBL1/2 by the pharmacological inhibitor CB6644 or vesicle-like nanoparticle-encapsulated siRNAs preferentially arrested the growth of YTHDF1-expressing colorectal cancer in vitro and in vivo. Our findings show that RUVBL1/2 are potential prognostic markers and druggable targets that regulate protein translation in YTHDF1-high colorectal cancer. Significance: RUVBL1/2 inhibition is a therapeutic strategy to abrogate YTHDF1-driven oncogenic translation and overcome m6A dysregulation in colorectal cancer.

SUBMITTER: Chen D 

PROVIDER: S-EPMC11372367 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.

Chen Danyu D   Ji Fenfen F   Zhou Qiming Q   Cheung Henley H   Pan Yasi Y   Lau Harry C-H HC   Liang Cong C   Yang Zhenjie Z   Huang Pingmei P   Wei Qinyao Q   Cheung Alvin H-K AH   Kang Wei W   Chen Huarong H   Yu Jun J   Wong Chi Chun CC  

Cancer research 20240901 17


The N6-methyladenosine (m6A) RNA-binding protein YTHDF1 is frequently overexpressed in colorectal cancer and drives chemotherapeutic resistance. To systematically identify druggable targets in colorectal cancer with high expression of YTHDF1, this study used a CRISPR/Cas9 screening strategy that revealed RUVBL1 and RUVBL2 as putative targets. RUVBL1/2 were overexpressed in primary colorectal cancer samples and represented independent predictors of poor patient prognosis. Functionally, loss of RU  ...[more]

Similar Datasets

| S-EPMC7144925 | biostudies-literature
| S-EPMC8867832 | biostudies-literature
| S-EPMC7016651 | biostudies-literature
| S-EPMC9691343 | biostudies-literature
| S-EPMC7595883 | biostudies-literature
| S-EPMC11282141 | biostudies-literature
| S-SCDT-EMBOR-2020-51519-T | biostudies-other
| S-EPMC9731691 | biostudies-literature
| S-EPMC6943363 | biostudies-literature
| S-EPMC11488328 | biostudies-literature